BP40 MULTICENTER PHASE II STUDY OF APATINIB, A NOVEL INHIBITOR OF VEGFR, IN HEAVILY PRETREATED PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER

Hu, Xi-chun; Zhang, Jian; Xu, Bing-he; Jiang, Ze-fei; Tong, Zhong-sheng; Zhang, Qing-yuan; Wang, Xiao-jia; Feng, Ji-feng; Pang, Dan-mei; Fan, Min-hao; Li, Jin; Wang, Bi-yun; Wang, Zhong-hua; Zhang, Qun-ling; Sun, Si; Liao, Chun-mei; Jiang, Hao-yuan; Shao, Zhi-min

期刊名称The Breast
作者Hu, Xi-chun; Zhang, Jian; Xu, Bing-he; Jiang, Ze-fei; Tong, Zhong-sheng; Zhang, Qing-yuan; Wang, Xiao-jia; Feng, Ji-feng; Pang, Dan-mei; Fan, Min-hao; Li, Jin; Wang, Bi-yun; Wang, Zhong-hua; Zhang, Qun-ling; Sun, Si; Liao, Chun-mei; Jiang, Hao-yuan; Shao, Zhi-min
卷第22卷
印刷ISSN0960-9776
文件大小53.39KB
发表时间2013-11
DOI10.1016/S0960-9776(13)70054-7

发现好书期刊，享受阅读乐趣

BP40 MULTICENTER PHASE II STUDY OF APATINIB, A NOVEL INHIBITOR OF VEGFR, IN HEAVILY PRETREATED PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER